Navient Corporation (NAVI)
NASDAQ: NAVI · Real-Time Price · USD
12.66
-0.28 (-2.16%)
At close: Aug 1, 2025, 4:00 PM
12.90
+0.24 (1.90%)
After-hours: Aug 1, 2025, 4:41 PM EDT
Augmedix Stock Forecast
Stock Price Forecast
The 8 analysts that cover Augmedix stock have a consensus rating of "Hold" and an average price target of $14.19, which forecasts a 12.09% increase in the stock price over the next year. The lowest target is $11 and the highest is $18.
Price Target: $14.19 (+12.09%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Augmedix stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 4 | 4 | 4 | 5 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 8 | 7 | 8 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $14 | Hold | Maintains | $15 → $14 | +10.58% | Jul 31, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +18.48% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $13 → $16 | Hold | Maintains | $13 → $16 | +22.43% | Jul 11, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | +30.33% | Jul 9, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $11 → $13 | Hold | Maintains | $11 → $13 | -1.26% | May 1, 2025 |
Financial Forecast
Revenue This Year
568.34M
from 848.00M
Decreased by -32.98%
Revenue Next Year
571.03M
from 568.34M
Increased by 0.47%
EPS This Year
1.10
from 1.18
Decreased by -7.14%
EPS Next Year
1.37
from 1.10
Increased by 24.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 621.6M | 653.1M | 751.8M |
| Avg | 568.3M | 571.0M | 730.3M |
| Low | 529.2M | 511.6M | 701.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -26.7% | 14.9% | 31.7% |
| Avg | -33.0% | 0.5% | 27.9% |
| Low | -37.6% | -10.0% | 22.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.21 | 1.64 | 1.51 |
| Avg | 1.10 | 1.37 | 1.47 |
| Low | 1.01 | 1.05 | 1.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.3% | 49.5% | 10.7% |
| Avg | -7.1% | 24.7% | 7.5% |
| Low | -14.8% | -4.3% | 3.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.